Abstract C6: EMC1/KIAA0090 overexpression enhances proliferation and motility in breast cancer cells

Abstract

Human KIAA0090 (EMC1) is an evolutionarily conserved and ubiquitously expressed gene that maps to a chromosomal region (1p36.13) with frequent aberrations in several types of cancer. The RefSeq mRNA (isoform 1) of human EMC1 encodes a highly conserved protein of 993 amino acids whose yeast ortholog was recently proposed to function in unfolded protein response (UPR) and/or endoplasmic reticulum-associated degradation (ERAD). Deletion of the gene in yeast and C. elegans leads to slow growth (reduced fitness), and studies using genetic approaches or affinity capture in yeast, human and flies have revealed interactors of EMC1 involved in multiple pathways, including cell cycle, secretory pathway, UPR, ERAD, ion transport, cytoskeleton, transcription factors, cell signaling and mitochondrial electron transfer. Accumulated evidence on the requirement of UPR components for tumor growth and maintenance besides potential involvement of human EMC1 in cancer as suggested by global gene-expression analyses prompted us to investigate the role of this protein in breast cancer progression. Using antibodies raised, in our laboratory, against the N-terminal half of human EMC1, we showed staining mostly restricted to the basal layer of mammary epithelium in normal tissues, whereas in breast cancer tissues strong staining especially of what appears to be invasive cells and associated vasculature was observed. Additionally, using a tissue microarray with 96 samples of invasive primary breast tumor, we observed staining for EMC1 predominantly in zones of invasion and of variable levels of intensity, that we classified in weak, moderate and strong. Most cases (80/96, 83%) showed moderate to strong intensity, and strong expression was more frequent in tumors of grade II. Also, we observed a positive correlation of EMC1 with estrogen and progesterone receptor expression. Furthermore, we stably transfected SKBR-3 cells, which bear HER-2 gene amplification, with full length EMC1 cloned into the pcDNA3 vector, and protein overexpression was confirmed by immunostaining and qRT-PCR. SKBR-3 cells, which have a typical epithelial feature of cuboidal shape and grow grouped together with one another, underwent a noticeable morphological change after EMC1 overexpression, characterized by a more flattened, mesenchymal-like morphology and sparse distribution. Prominent filopodia, revealed by phalloidin labeling, was also observed after EMC1 exogenous expression. Additionally, EMC1 overexpression also enhanced motility and proliferation of SKBR-3 cells through ERK1/2 activation. Citation Format: Roberto Augusto Silva Molina, Rodrigo Ribeiro Silva, Josane Freitas Souza, Milene Mantovani Lopes, Daniel Guimaraes Tiezzi, Enilza Maria Espreafico. EMC1/KIAA0090 overexpression enhances proliferation and motility in breast cancer cells. [abstract]. In: Proceedings of the AACR Special Conference on Tumor Invasion and Metastasis; Jan 20-23, 2013; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2013;73(3 Suppl):Abstract nr C6.

A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis

“…KIAA0090, ATAD3B, TRIM27 and DMTF1, regulated by hypo-methylated sites, were also associated with cancer. KIAA0090, which was positively related with hypo-methylated cg00894870, was associated with cancer metastasis and prognosis [ 16 ]. ATAD3B was expressed in cancer cell, and may related with tumorigenesis, proliferation and chemoresistance [ 14 , 15 ].…”

“…These subtypes were mainly determined by DNA methylation information, and all the selected biomarkers were also methylation sites. Five methylation sites (cg00894870, cg03041700, cg08356572, cg11416447 and cg22627950) were selected as biomarkers for both LUSC-C1 and LUSC-C3, in which the function of 4 methylated genes were associated with cancer [13][14][15][16][17][18]. The function of 267 genes were mainly associated with regulation of cell cycle and gene transcription.…”